AS

Abdulmonaim Shaikh

Active Director Director DIN 09472463
DIN 09472463 First appointment Jan 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdulmonaim Shaikh

Data last updated:

Abdulmonaim Shaikh is a Director at Mednock Pharmaceutical Private Limited (since 2022). The company operates in Pharma.

DIN 09472463
Primary Designation Director
Industry Pharma
First Appointment 18 Jan 2022
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jan 20222016Active

Directorship timeline

Open interactive timeline →
Mednock Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Abdulmonaim Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdulmonaim Shaikh

Abdulmonaim Shaikh currently holds 1 directorship: Mednock Pharmaceutical Private Limited (Director, since 18 Jan 2022).

Abdulmonaim Shaikh was first appointed on 18 Jan 2022 as Director at Mednock Pharmaceutical Private Limited.

The current boards of Abdulmonaim Shaikh's companies include Afaque Abbas (Mednock Pharmaceutical Private Limited), Pankaj Pandey (Mednock Pharmaceutical Private Limited), Rafia Absar Shaikh (Mednock Pharmaceutical Private Limited), Raiyan Shaikh (Mednock Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available